NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily shot aims to shrink dangerous liver fat
Disease control Recruiting nowThis study is testing whether a daily injection called tesamorelin can reduce fat buildup in the liver of adults with fatty liver disease. 120 participants will receive either the active drug or a placebo injection for one year, with both groups receiving lifestyle advice. The ma…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
Veterans trial aims to halt fatty liver disease with common hormone
Disease control Recruiting nowThis study is testing whether a low dose of thyroid hormone can treat a serious form of fatty liver disease called NASH in Veterans. Researchers believe the hormone may help the liver's energy centers burn excess fat more effectively. The trial will compare the hormone against a …
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Researchers probe link between HIV drugs and dangerous liver fat
Knowledge-focused Recruiting nowThis study aims to understand if different types of HIV medication affect the development of fatty liver disease. Researchers will follow 200 Chinese patients with HIV to see if starting or switching certain drugs leads to more severe liver fat buildup or scarring. The goal is to…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Massive 15,000-Person study launches to map the hidden journey of fatty liver disease
Knowledge-focused Recruiting nowThis study is creating a large registry to track the health journeys of people with nonalcoholic fatty liver disease (NAFLD) and its more serious form, NASH. It aims to understand how the disease progresses and what treatments doctors are using in everyday practice, since there a…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC